Patent for nutraceutical to manage gut health developed by Kerala University researchers

4 months ago 2
ARTICLE AD BOX

Gut health, peculiarly a divers and balanced gut microbiota, plays a important relation successful one’s wide well-being, influencing immunity, metabolism, intelligence health, and illness prevention.

There are caller meta-analyses which corroborate associations betwixt higher microbiome diverseness and amended intelligence well-being, portion dysbiosis (imbalance successful the microbiota) links to conditions similar obesity, metabolic syndrome, and chronic inflammation.

A poly-herbal nutraceutical composition, which is designed to negociate gut dysbiosis, heighten gut microbial diversity, and enactment metabolic health, developed by 2 researchers astatine the Department of Biochemistry, University of Kerala, has been granted patent by the Office of the Controller General of Patents, Designs and Trade Marks (CGPDTM), nether the Ministry of Commerce and Industry. The University of Kerala is the patentee.

The improvement of the nutraceutical, PolyNutriBio (PNBio), was a three-year probe task taken up by A. Helen, erstwhile Head of the Biochemistry section and Maya G. Pillai, Scientist, who has done extended probe connected inflammation. The task was funded by the Department of Health Research, Indian Council of Medical Research.

The gut is the largest immune organ successful the assemblage arsenic astir 70% of the body’s immune cells are located successful the tissues lining the gut. The gut microbiome, which consists of trillions of microbes, does not conscionable assistance digestion, they support the gut obstruction integrity and modulate the immune system.

Chronic inflammatory disorders, including benignant 2 diabetes mellitus, rheumatoid arthritis, and atherosclerosis originate from analyzable interactions betwixt genetic, biology and manner factors, starring to persistent systemic inflammation and gut dysbiosis.

Gut dysbiosis oregon an imbalance successful gut microbiota creation owed to mediocre diet, overuse of antibiotics, oregon stress, aggravates the body’s inflammatory state. Though non-steroidal anti-inflammatory drugs and lipid-lowering agents tin supply impermanent relief, these drugs person their ain broadside effects.

‘A holistic alternative’

“The poly-herbal nutraceutical, PolyNutriBio (PNBio), is simply a holistic alternate that targets some systemic inflammation and gut dysbiosis. It is simply a plant-based, fibre-rich nutrient supplement that we person formulated, a operation of selected anti-inflammatory agents, which volition person the gut from a pro-inflammatory to anti-inflammatory state,” said Dr. Helen, who presently heads the Department of Computational Biology and Bioinformatics.

She said that the pre-clinical studies successful laboratory animals revealed PNBio’s imaginable successful managing acute inflammation, and besides showed efficacy successful reducing humor glucose, full cholesterol, LDL-cholesterol, triglycerides and modulation of cytokine signalling molecules.

Metabolomic investigation revealed cardinal bioactive metabolites specified arsenic muricholic acerb and beta-Dmannopyranose, supporting gut wellness and systemic inflammation reduction.

Additionally, microbiome profiling indicated an summation successful beneficial bacterial taxon similar Akkermansia muciniphila which is reported arsenic a next-generation probiotic and Bifidobacterium adolescentis, highlighting PNBio’s relation successful restoring gut microbial balance.

“We person besides completed the signifier 1 90 days’ quality trials. The adjacent measurement would beryllium signifier 2 trials successful persons with inflammatory diseases to measure the efficacy of the supplement’s anti-inflammatory properties. We anticipation our probe volition yet scope people,” Dr. Helen said.

The patent marks an important measurement towards the improvement of evidence-based nutraceuticals, and highlights the University of Kerala’s publication to translational and applied wellness research, she added.

Published - January 18, 2026 06:56 p.m. IST

Read Entire Article